Recently published Autoimmune Uveitis Market Insights report includes a comprehensive understanding of current treatment ...

Wall Street analysts believe that a more cautious approach to manufacturing, study enrollment and side effect management ...

Novartis halted eight clinical trials of an experimental therapy targeting autoimmune and neurological disorders in late ...

Novartis instituted program-wide clinical holds across eight Rap‑cel autoimmune trials after three IEC‑HS events with fatal outcomes, prompting regulator engagement and comprehensive cross-program ...

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease that particularly affects young adults. The disease is ...

Our immune system has a dark side: It's supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. New research is raising the prospect of ...

Novartis AG temporarily paused trials of an experimental cell therapy for autoimmune diseases after three patients died.

Trials testing an experimental medication have been urgently halted following the death of multiple participants due to ...

Early in the coronavirus pandemic, it became clear that COVID-19 could cause serious disruptions to the immune system in some people. For people with autoimmune diseases, in which the immune system ...

Sept 1 (Reuters) - Novartis paused eight clinical trials of an experimental therapy targeting autoimmune and neurological ...

Thanks in part to the revolution cell therapy brought to treating blood cancers, the modality is now showing promise in some ...

Biopharmas developing CAR T therapies for autoimmune indications face major barriers to maximizing the market. Advances in ...